NSEAnalysts/Institutional Investor Meet/Con. Call Updates1d ago · 17 Sept 2026, 12:51 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Cohance Lifesciences Limited · COHANCE
✦ AI SummaryMgmt Change
Cohance Lifesciences Limited has informed the Exchange about Schedule of Analysts/ Institutional Investors Meet, where the management will be attending JP Morgan India Conference in Mumbai and JP Morgan Roadshow in Hyderabad.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Cohance Lifesciences Limited has informed the Exchange about Schedule of Analysts/ Institutional Investors Meet
Attachments (1)
📄pdf
Download →
SUVENPHARMROHIT_17092026125044_Cohance_Disclosure_Investor_Meet.pdf
View document text
17 September 2026
To To
BSE Limited National Stock Exchange of India Limited
25th Floor, P. J. Towers, Exchange Plaza, Bandra Kurla Complex
Dalal Street, Mumbai - 400 001 Bandra (E), Mumbai – 400 051
Code: 543064 Symbol: COHANCE
Dear Sir/Madam,
Sub: Intimation regarding Analysts/ Institutional Investors Meet
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,
please note that the management of the Company will be attending the below mentioned Conferences:
Date Conference Location Group/One-one
22 September 2026 JP Morgan India Conference Mumbai Group and One-on-One
24 September 2026 JP Morgan Roadshow Hyderabad Group
Note:
The schedule of the aforesaid meets is subject to change. The change may happen due to exigencies on the
part of Analyst/ Institutional Investor/ Company.
No unpublished price-sensitive information will be shared during this interaction.
You are requested to take the above on record.
Thanking you.
Yours faithfully,
For Cohance Lifesciences Limited
(formerly, Suven Pharmaceuticals Limited)
Sisir K. Mishra
Company Secretary & Compliance Officer